[section_title title=Page 1 - The Story Of Accutane]
Accutane also known as Roaccutane, Retin A (active ingredient: isotretinoin) is an acne treatment drug which was manufactured by a pharmaceutical company named Roche, but was pulled from the market in June 2009.
It began its controversial life in 1982 and was originally intended for the treatment of brain, pancreatic and other cancers. But later became the blockbuster drug in treating severe acne conditions that no other drug could match, but was also the last drug of choice due to it’s list of potential side effects.
In 2002, Hoffman-La Roche lost its patent protection on the Accutane drug, which saw an increase in generic forms of the drug coming on to the market manufactured by other pharmaceutical companies who wanted a slice of the cash pie.
Although Roche ceased production of the Accutane drug, claiming that they were losing too much money because of lawsuits and generic forms of the drug coming onto the market, it can still be prescribed by or under the supervision of a dermatologist in the UK.
It is also available in the US under the control of a FDA mandate website known as iPLEDGE, which requires dermatologists to register their patients before administration of the drug can be given and dispensed by a pharmacist. In Australia and New Zealand it remains freely available, again under the guidance of a general practitioner or dermatologist despite the appalling list of side effects and growing numbers of law suits.
Even though the drug is intended for more severe forms of acne like cystic acne vulgaris, where other drugs have proven ineffective, it has been prescribed and continues to be prescribed to patients with much milder forms of the condition.